ENDOTHELIAL GATA4 IN ATHEROSCLEROSIS PROGRESSION

内皮 GATA4 在动脉粥样硬化进展中的作用

• 批准号: MR/W00366X/1
• 负责人: Paul Evans
• 金额: $ 59.39万
• 依托单位: University of Sheffield
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=MR%2FW00366X%2F1
• 关键词: ENDOTHELIAL; GATA4; ATHEROSCLEROSIS; PROGRESSION

Atherosclerosis is a disease of arteries that is a leading cause of death. It is characterised by the build-up of fatty deposits called plaques. Some plaques develop into dangerous forms that can rupture leading to heart attack or stroke. This process is driven by complex blood flow patterns at bends or branches of arteries. The mechanisms of this link, which are currently unknown, could inform new therapies to prevent plaque rupture. To elucidate them, we used an unbiased approach to identify and characterise flow-responsive genes and found that the transcription factor GATA4 was unique in driving multiple processes (inflammation, proliferation, apoptosis) that are known to promote plaque rupture. The proposed work brings together a group of basic scientists and clinicians to test the hypothesis that GATA4 is a master regulator of endothelial pathogenic change and that targeting of the GATA4 pathway can reduce the risk of rupture in diseased arteries. We propose an ambitious project of research including the use of conditional knockouts in mice and analysis of human coronary artery plaques to determine the role of endothelial GATA4 in driving plaque progression towards dangerous rupture-prone forms. Importantly, the GATA4 pathway has not been studied previously in atherosclerotic plaques and it therefore represents a novel and valuable resource in terms of potential new drug targets. Indeed, we propose to identify molecular targets in the GATA4 pathway that may be amenable to pharmacological modulation and can be followed-up in future studies. The proposed research project has high potential impact because it will lead to the identification of molecular targets in the GATA4 pathway that can be targeted to reduce the risk of plaque rupture, benefiting patients at risk of heart attack or stroke.

动脉粥样硬化是一种动脉疾病，是导致死亡的主要原因。它的特点是脂肪沉积的积累，称为斑块。一些斑块发展成危险的形式，可能破裂导致心脏病发作或中风。这一过程是由动脉弯曲或分支处复杂的血流模式驱动的。这种联系的机制目前尚不清楚，但可以为预防斑块破裂的新疗法提供信息。为了阐明它们，我们使用了一种无偏倚的方法来识别和表征流动响应基因，并发现转录因子GATA4在驱动已知促进斑块破裂的多个过程（炎症、增殖、凋亡）中是独特的。这项提议的工作汇集了一组基础科学家和临床医生，以验证GATA4是内皮致病性变化的主要调节剂的假设，以及靶向GATA4途径可以降低病变动脉破裂的风险。我们提出了一个雄心勃勃的研究项目，包括在小鼠中使用条件敲除和分析人类冠状动脉斑块，以确定内皮GATA4在驱动斑块向危险的易破裂形式发展中的作用。重要的是，GATA4通路以前在动脉粥样硬化斑块中没有被研究过，因此它代表了一种新的有价值的潜在新药靶点资源。事实上，我们建议在GATA4途径中确定可能适合药理调节的分子靶点，并可以在未来的研究中进行后续研究。该拟研究项目具有很高的潜在影响，因为它将导致鉴定GATA4途径中的分子靶点，可以靶向降低斑块破裂的风险，使有心脏病发作或中风风险的患者受益。

项目成果

Translational opportunities of single-cell biology in atherosclerosis.

• DOI: 10.1093/eurheartj/ehac686
• 发表时间: 2023-04-07
• 期刊: EUROPEAN HEART JOURNAL
• 影响因子: 39.3
• 作者: de Winther, Menno P. J.;Back, Magnus;Evans, Paul;Gomez, Delphine;Goncalves, Isabel;Jorgensen, Helle F.;Koenen, Rory R.;Lutgens, Esther;Norata, Giuseppe Danilo;Osto, Elena;Dib, Lea;Simons, Michael;Stellos, Konstantinos;Yla-Herttuala, Seppo;Winkels, Holger;Bochaton-Piallat, Marie-Luce;Monaco, Claudia
• 通讯作者: Monaco, Claudia